Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) (Q85063666)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 September 2011
edit
Language Label Description Also known as
English
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
scientific article published on 14 September 2011

    Statements

    title
    Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS) (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    21982649
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21982649%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    14 February 2020

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q85063666&oldid=2118762364"